Le Lézard
Classified in: Covid-19 virus
Subjects: Survey, Economic News/Analysis

Best's Special Report: U.S. Publicly Traded Life/Annuity Insurers' Revenues Off 12% in 2022

Premium growth for publicly traded U.S. life/annuity (L/A) insurance companies continued to recover in 2022, but was countered by declines in investment and fee income that drove total GAAP revenue down by 12% to $291.5 billion, according to a new AM Best report.

According to the Best's Special Report, another factor contributing to the revenue decline was $22.9 billion in realized losses, which were reported at all but three of the 18 companies used in the analysis. More than half of these companies saw an increase in premium revenue, while nearly all saw a drop in fee income, as declines in assets under management were more widespread.

"Many of the publicly traded life insurance companies have substantially reduced their product offerings in recent years due to the low interest rate environment, which made achieving targeted profit margins difficult," AM Best Associate Director Jason Hopper said. "Because of the COVID-19 pandemic, consumers have gravitated toward protection products such as indexed universal life."

The report also notes that with rising interest rates in 2022, L/A insurers ramped up fixed annuity production and were able to invest in higher-yielding securities and offer higher crediting rates. However, carriers began to pull back on fixed annuity sales in the latter half of 2022 to conserve capital and focus on building a more diverse product offering.

Other report highlights include:

To access the full copy of this special report, "Premiums Grow, Revenue Drops for Public Life/Annuity GAAP Insurers," please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=330627.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in New York, London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2023 by A.M. Best Company, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

These press releases may also interest you

at 12:42
Canadians deserve a health care system that provides timely access to quality health services and medications, regardless of where they live or their ability to pay. The Government of Canada recognizes that concerted and collaborative efforts by...

at 11:00
The "US Education Market (K-12, Post-Secondary, Corporate Training & Child Care): Insights & Forecast (2024-2028)" report has been added to ResearchAndMarkets.com's offering. The U.S. education market is expected to record a value of US$2.25...

at 11:00
The global Cardiovascular Health Supplements Market is estimated to be valued at US$ 9.85 Bn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights....

at 10:15
Join us on the latest episode of AudioTalks as we dive into the exciting world of JBL Land on Roblox! Our special guests include:Tonya Filonenko, Social Media Manager for JBL Land and the Roblox Lead at Harman InternationalTim van der Wiel, Founder...

at 09:03
National and international nominations are being sought for the 2025 Harrington Prize for Innovation in Medicine, which honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and the potential...

at 09:02
The life science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announces its comprehensive suite of eco-conscious, cost-effective innovations tailored for diagnostic...

News published on and distributed by: